Neuron23
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
2
Funding Rounds
$180.0m
Money raised
Overview
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Kn**** | - | - | - |
Funding series
Funding Series Analysis
The company Neuron23 has raised a total of $100m in funding over 2 rounds.
Key Insights:
- Neuron23 Series C round: $100m
- Neuron23 Series B round December 2020: $80m
Neuron23 Series C round
$100m
Neuron23 Series B round December 2020
$80m
Industries
Neuron23 is active in the following industries: